# Allakos (stock symbol: ALLK) Logo in transparent PNG and SVG formats

## Allakos Logo large

### Allakos Logo large Download PNG (42.41 KB)

![Allakos Logo large Download PNG (42.41 KB)](/img/orig/ALLK_BIG-94acce19.png)

### Allakos Logo large Download SVG (26.2 KB)

![Allakos Logo large Download SVG (26.2 KB)](/img/orig/ALLK_BIG-767b8cd2.svg)

## Allakos Logo icon format

### Allakos Logo icon format Download PNG (128.68 KB)

![Allakos Logo icon format Download PNG (128.68 KB)](/img/orig/ALLK-8043c23b.png)

### Allakos Logo icon format Download SVG (27.72 KB)

![Allakos Logo icon format Download SVG (27.72 KB)](/img/orig/ALLK-399eae60.svg)

## Allakos Logo large for dark backgrounds

### Allakos Logo large for dark backgrounds Download PNG (28.67 KB)

![Allakos Logo large for dark backgrounds Download PNG (28.67 KB)](/img/orig/ALLK_BIG.D-beb3c868.png)

### Allakos Logo large for dark backgrounds Download SVG (26.15 KB)

![Allakos Logo large for dark backgrounds Download SVG (26.15 KB)](/img/orig/ALLK_BIG.D-8daf0df1.svg)

## Allakos Logo icon format for dark backgrounds

### Allakos Logo icon format for dark backgrounds Download PNG (80.05 KB)

![Allakos Logo icon format for dark backgrounds Download PNG (80.05 KB)](/img/orig/ALLK.D-dce600f7.png)

### Allakos Logo icon format for dark backgrounds Download SVG (27.67 KB)

![Allakos Logo icon format for dark backgrounds Download SVG (27.67 KB)](/img/orig/ALLK.D-5da7fbae.svg)

## About Allakos

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

1. Website domain: allakos.com
2. Employees: 192
3. Marketcap: $0.36 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
